Tagged with Strategy

Taiwan C.Y. Cheng, chairman and president of Formosa Laboratories, shares exciting news about the establishment of a new drug development company, Formosa Pharmaceuticals. He explains how the know-how gained from running a successful international API production business will help Formosa avoid the typical mistakes that young R&D companies face. Mr. Cheng,…

Taiwan Chih-Yi Weng, chairlady and CEO of Charsire Biotechnology, one of Taiwan’s leading biotech companies focused on the development of botanical new drugs as well as topical and personal care products, provides insights into the company’s unique business model and its promising and maturing R&D pipeline, while Charsire was ranked in…

Switzerland The southern Swiss canton of Ticino does not have the life science reputation of Basel, Zurich or Geneva, but benefits from an open business environment, strategic location, and a thriving network of pharmaceutical SMEs. “Ticino is really a perfect example of the excellence of Swiss SMEs in the pharma industry, as…

Taiwan Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s revenues within the next five years and nurture the long-term growth of the company he founded in 1982, while OEP’s…

Taiwan Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s revenues within the next five years and nurture the long-term growth of the company he founded in 1982, while OEP’s…

Indonesia Alban Nérot, managing director at Servier Indonesia, explains the transformational change of the Indonesian affiliate to ensure the sustainable growth of its business in the country as well as the importance of medical education to show to doctors and other healthcare professionals the benefits of innovative medicine. Mr. Nérot, you…

Mexico Spearheading one of the most trusted and recognizable pharmacy chain brands in the country, Isaac Valdivieso, Director General of Farmacia San Pablo, shares his insights about the company’s stance in the market. He speaks about building an efficient corporate strategy, the customer-centric approach that sets them apart from the competition,…

Mexico By his own admission. Metrohm CEO Jodok Reinhardt has a dream job. He reveals how the company has become a successful and slightly different outfit when it comes to supplying the very latest chemical analysis instruments. Metrohm has grown from a start-up in the 1940s to one of the most…

Mexico Gabriela Báez, Chief Commercial Officer of Up Pharma, elaborates on the company’s unique business model that supports small to medium sized pharmaceutical and preventative health companies in entering the Mexican market. In terms of your portfolio, what is the breakdown of your services and where do see the most growth?…

Mexico Dominik Bacher, founder and CEO at Bacher Zoppi, explains the latest changes in the commercialization stage of the healthcare industry and showcases the value proposition of Bacher Zoppi to successfully implement sustainable sales strategies. After slowing in 2012-13, Mexico’s pharmaceutical sector is expected to grow on average 5.6 percent rising…

Ireland David Adlam, Regional Manager of Ireland and South West UK, and Paul Morris, Strategic Account Manager for Life Sciences at Agility, discuss the company’s increased commitment to Ireland, their ongoing and successful efforts to expand their portfolio of life science clients as well as their focus on niche product areas.…

Switzerland Susanne Hoeppner, GM of Astellas Switzerland and board member of vips, discusses her key priorities, the culture of Swiss pharma, and the industry-wide push for faster approval times. Ms. Hoeppner, in addition to your role as general manager of Astellas, we understand you also have leadership role within the industry…